EVGRF logo

China Evergrande New Energy Vehicle Group Limited (EVGRF) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

China Evergrande New Energy Vehicle Group Limited (EVGRF) opera en el sector Healthcare, cotizado por última vez a $ con una capitalización de mercado de 0. La acción obtiene una puntuación de 60/100, una calificación moderada basada en 9 KPI cuantitativos.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 60/100

China Evergrande New Energy Vehicle Group Limited (EVGRF) Resumen de Asistencia Médica y Tuberías

CEOShawn Siu
Empleados829
Sede CentralGuangzhou, CN
Año de la oferta pública inicial (OPI)2021

China Evergrande New Energy Vehicle Group Limited stands at the intersection of healthcare and sustainable transportation, offering a diverse portfolio that includes health management services and new energy vehicles, positioning itself as a multifaceted player in both sectors.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

China Evergrande New Energy Vehicle Group Limited presents a unique investment thesis driven by its dual focus on healthcare services and new energy vehicle production. The company's market cap of $0.01 billion and a P/E ratio of -0.14 indicate current challenges, yet its strategic initiatives in health management and new energy vehicles could unlock significant growth potential. The ongoing global shift towards sustainable practices and healthcare innovation presents a favorable backdrop for the company's expansion. Key value drivers include its diversified service offerings, potential for market share growth in the health management sector, and the increasing demand for new energy vehicles. The company's commitment to research and development in pharmaceuticals and medical technology further enhances its competitive positioning. However, investors should remain cautious of the negative profit margin of -890.5% and the gross margin of -3.8%, which highlight underlying operational challenges that need to be addressed for sustainable growth.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market cap of $0.01 billion reflects the company's current valuation amidst operational challenges.
  • P/E ratio of -0.14 indicates negative earnings, suggesting potential financial instability.
  • Profit margin of -890.5% highlights significant operational losses that need addressing.
  • Gross margin of -3.8% indicates challenges in maintaining profitability in its business segments.
  • Beta of 1.12 suggests higher volatility compared to the market, reflecting investor sentiment.

Competidores y Pares

Fortalezas

  • Diverse portfolio combining healthcare and new energy vehicle sectors.
  • Established presence in the Chinese healthcare market.
  • Strong potential for growth in the new energy vehicle segment.
  • Commitment to research and development fostering innovation.

Debilidades

  • Negative profit margin indicating operational challenges.
  • High volatility reflected in beta of 1.12.
  • Limited brand recognition outside of China.
  • Dependence on the domestic market for most revenue.

Catalizadores

  • Upcoming: Expansion of healthcare services to meet rising demand in urban areas.
  • Ongoing: Development of new energy vehicles aligning with global sustainability trends.
  • Upcoming: Introduction of innovative healthcare technology solutions to enhance service delivery.
  • Ongoing: Strategic partnerships with healthcare organizations to broaden market reach.
  • Upcoming: Launch of new medical products and services in response to consumer needs.

Riesgos

  • Potential: Regulatory changes impacting healthcare and automotive operations.
  • Ongoing: Financial instability reflected in negative profit margins.
  • Potential: Competition from established players in both healthcare and new energy sectors.
  • Ongoing: Economic downturns affecting consumer spending on healthcare services.

Oportunidades de crecimiento

  • Growth opportunity 1: The global health management market is expected to reach $1 trillion by 2027, driven by increasing consumer awareness and demand for personalized healthcare services. China Evergrande's focus on community health management and elderly care positions it to capture a significant share of this expanding market, particularly in urban areas where healthcare access is critical.
  • Growth opportunity 2: The new energy vehicle market is projected to grow at a CAGR of 22% through 2027, driven by technological advancements and regulatory support for sustainable transportation. China Evergrande's investments in smart mobility solutions and lithium-ion battery production place it in a favorable position to benefit from this growth, particularly as global demand for electric vehicles continues to rise.
  • Growth opportunity 3: The increasing prevalence of chronic diseases in China presents a substantial opportunity for the company's healthcare services. By expanding its offerings in medical cosmetology and anti-aging services, China Evergrande can tap into the growing consumer demand for preventative health measures and wellness solutions, potentially increasing its revenue streams.
  • Growth opportunity 4: With the rise of telemedicine and digital health solutions, China Evergrande's software services can play a crucial role in enhancing healthcare delivery. By integrating technology into its health management services, the company can improve patient engagement and outcomes, positioning itself as a leader in innovative healthcare solutions.
  • Growth opportunity 5: The company's commitment to research and development in pharmaceuticals and medical equipment production presents opportunities for innovation and market differentiation. By developing proprietary technologies and products, China Evergrande can enhance its competitive advantage and drive revenue growth in both the healthcare and new energy sectors.

Oportunidades

  • Growing demand for health management services in aging populations.
  • Expansion potential in the new energy vehicle market.
  • Increasing interest in telemedicine and digital health solutions.
  • Potential partnerships with government and healthcare organizations.

Amenazas

  • Intense competition from established healthcare and automotive companies.
  • Regulatory challenges in the healthcare and automotive sectors.
  • Economic fluctuations impacting consumer spending on healthcare.
  • Technological advancements by competitors could outpace company innovations.

Ventajas competitivas

  • Diversified service offerings that cater to both healthcare and sustainable transportation.
  • Established brand reputation in the health management sector.
  • Strategic investments in research and development for innovative solutions.
  • Strong presence in the rapidly growing new energy vehicle market.
  • Ability to leverage economies of scale in production and distribution.

Acerca de EVGRF

Founded in 1999, China Evergrande New Energy Vehicle Group Limited, originally known as Evergrande Health Industry Group Limited, has evolved into a prominent investment holding company headquartered in Guangzhou, China. The company operates primarily in the healthcare sector, focusing on health management services and the development of new energy vehicles. With a commitment to enhancing community health, it provides a range of services, including community health management, medical cosmetology, anti-aging services, elderly care, and rehabilitation. In addition to healthcare services, China Evergrande New Energy Vehicle Group is involved in the wholesale of home care and healthcare products, alongside software services that support healthcare delivery. The company also engages in pharmaceutical research and development, medical equipment production, and the manufacture and sale of smart mobility solutions and lithium-ion batteries. Its strategic pivot to new energy vehicles reflects a growing emphasis on sustainability and innovation in transportation, aligning with global trends towards eco-friendly solutions. This diversification not only broadens its market reach but also positions the company favorably within the rapidly evolving landscape of health management and new energy sectors.

Qué hacen

  • Develops and sells health and living properties.
  • Provides community health management services.
  • Offers medical cosmetology and anti-aging services.
  • Delivers elderly care and rehabilitation services.
  • Wholesale of home care and healthcare products.
  • Engages in pharmaceutical research and development.
  • Produces medical equipment and smart mobility solutions.
  • Manufactures and sells lithium-ion batteries.

Modelo de Negocio

  • Revenue generated through health management services and community health programs.
  • Sales from new energy vehicles and related products.
  • Wholesale distribution of healthcare products and medical equipment.
  • Software services that support healthcare delivery and management.
  • Research and development initiatives that lead to innovative healthcare solutions.

Contexto de la Industria

The healthcare sector, particularly in medical care facilities, is experiencing significant growth driven by an aging population and increasing demand for health management services. The global market for healthcare services is projected to expand as consumers seek comprehensive care solutions. Concurrently, the new energy vehicle market is witnessing rapid advancements, with a projected CAGR of 22% through 2027, driven by technological innovations and government incentives for sustainable transportation. China Evergrande New Energy Vehicle Group Limited is strategically positioned within this competitive landscape, leveraging its dual focus on health management and new energy vehicles to capitalize on emerging market trends.

Clientes Clave

  • Individuals seeking health management and wellness services.
  • Elderly patients requiring rehabilitation and care.
  • Healthcare facilities needing medical equipment and products.
  • Consumers interested in new energy vehicles and smart mobility solutions.
  • Government and private organizations looking for community health management partnerships.
Confianza de la IA: 72% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de China Evergrande New Energy Vehicle Group Limited (EVGRF): Price data unavailable

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para EVGRF.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para EVGRF.

MoonshotScore

60/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de EVGRF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Shawn Siu

CEO

Shawn Siu has been instrumental in guiding China Evergrande New Energy Vehicle Group Limited through its strategic transformation. With a strong background in business management and operations, he has overseen the company's expansion into new markets and sectors. Siu holds a degree in Business Administration and has extensive experience in the healthcare and automotive industries, which positions him well to lead the company in its dual focus on health management and new energy vehicles.

Historial: Under Shawn Siu's leadership, the company has diversified its offerings and strengthened its market position. His strategic decisions have led to increased investments in research and development, positioning China Evergrande to capitalize on emerging trends in both healthcare and sustainable transportation.

Información del mercado OTC de EVGRF

The OTC Other tier includes companies that do not meet the listing requirements of major exchanges like NYSE or NASDAQ. These stocks may have lower liquidity and higher volatility, making them riskier investments. Companies in this tier often provide less financial transparency, which can be a concern for investors.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity in OTC markets can be lower than on major exchanges, leading to wider bid-ask spreads and potentially higher trading costs. Investors may face challenges in executing large orders without impacting the stock price significantly.
Factores de riesgo OTC:
  • Limited financial disclosures may result in a lack of transparency.
  • Higher volatility and lower liquidity compared to stocks on major exchanges.
  • Potential for significant price fluctuations based on market sentiment.
  • Regulatory scrutiny may impact operations and stock performance.
Lista de verificación de diligencia debida:
  • Verify the company's financial health through available reports.
  • Assess the management team's experience and track record.
  • Evaluate the competitive landscape and market positioning.
  • Understand the regulatory environment affecting the business.
  • Monitor industry trends that may impact growth prospects.
Señales de legitimidad:
  • Established history since 1999 in the healthcare sector.
  • Diverse product offerings across healthcare and automotive sectors.
  • Affiliation with China Evergrande Group enhances credibility.
  • Engagement in research and development indicates commitment to innovation.

EVGRF Preguntas Frecuentes sobre Acciones de Healthcare

¿Cuáles son los factores clave para evaluar EVGRF?

China Evergrande New Energy Vehicle Group Limited (EVGRF) actualmente tiene una puntuación IA de 60/100, indicando puntuación moderada. Fortaleza clave: Diverse portfolio combining healthcare and new energy vehicle sectors.. Riesgo principal a monitorear: Potential: Regulatory changes impacting healthcare and automotive operations.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de EVGRF?

EVGRF actualmente puntúa 60/100 (Grado B) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de EVGRF?

Los precios de EVGRF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre EVGRF?

La cobertura de analistas para EVGRF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en EVGRF?

Las categorías de riesgo para EVGRF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Regulatory changes impacting healthcare and automotive operations.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de EVGRF?

La relación P/E para EVGRF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está EVGRF sobrevalorada o infravalorada?

Determinar si China Evergrande New Energy Vehicle Group Limited (EVGRF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de EVGRF?

China Evergrande New Energy Vehicle Group Limited (EVGRF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Financial data is based on the latest available information; operational challenges may impact future performance.
Fuentes de datos

Popular Stocks